NCT04997447

Brief Summary

Apparently healthy and well-functioning community dwelling 70-80 year-olds will be recruited to the study. All subjects undergo pre-screening for suitability and a physicians examination, as well as 7-day habitual daily steps are measured to ascertain baseline physical activity. Half of the recruited subjects (n=40) will be randomized into the intervention group and half (n=40) randomized into the control group. The intervention group is then required to reduce their daily steps to \<2000 for a 2-week period. Thereafter, the intervention group participates to a 4-week strength+endurance training rehabilitation program and no longer has restricted daily step count. The control group continues their normal habitual physical activity level throughout the 6-week study period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 9, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

September 15, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 22, 2021

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 22, 2022

Completed
Last Updated

August 21, 2023

Status Verified

August 1, 2023

Enrollment Period

3 months

First QC Date

July 1, 2021

Last Update Submit

August 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lean leg mass

    DXA-measured total lean mass of the legs

    6 weeks

Secondary Outcomes (7)

  • Whole-body fat mass

    6 weeks

  • Maximum isometric leg extension force

    6 weeks

  • Walking economy

    6 weeks

  • Short Physical Performance Battery (SPPB)

    6 weeks

  • Blood pressure

    6 weeks

  • +2 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Two weeks of daily step reduction (limited to 2000 steps per day) followed by four weeks of supervised gym-based exercise rehabilitation (twice per week strength training and twice per week cycle endurance training)

Behavioral: Step-reduction/Exercise Rehab

Control group

NO INTERVENTION

Continued monitoring of habitual daily step count without structured intervention. Classic control.

Interventions

2-week limited daily steps (\<2000), and then 4 weeks of typical strength+endurance exercise for older adults

Intervention group

Eligibility Criteria

Age70 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • aged 70-80 years,
  • community-dwelling,
  • able to walk 500 m without assistance or use of walking aid and regularly walking \>5000 steps per day,
  • MMSE \>24,
  • BMI 20-35 kg·m2 (i.e. not underweight or severely obese),
  • no serious cardiovascular or musculoskeletal disease,
  • no risk factors for deep-vein thrombosis (e.g. blood clotting disorder, obesity, bowel diseases, personal or family history of DVT etc.),
  • non-smoker,
  • provision of informed consent.

You may not qualify if:

  • Underlying diseases likely to limit lifespan and/or intervention safety. Contraindication for physical exercise or physical tests identified during physician's examination,
  • unwilling/unable to track daily step counts using accelerometer,
  • excessive and regular use of alcohol (more than 7 units per week for women and 14 for men)
  • difficulty in communication due to severe vision or hearing problems
  • unwilling to provide consent or accept randomization into either study group

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Jyväskylä

Jyväskylä, Central Finland, 40014, Finland

Location

MeSH Terms

Conditions

Body Weight ChangesMobility Limitation

Condition Hierarchy (Ancestors)

Body WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Simon Walker, PhD

    University of Jyväskylä, Finland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial, with 2 parallel groups
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2021

First Posted

August 9, 2021

Study Start

September 15, 2021

Primary Completion

December 22, 2021

Study Completion

November 22, 2022

Last Updated

August 21, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations